Year archive

Ocumension Therapeutics — 2021 filings

All 77 regulatory filings released by Ocumension Therapeutics (1477) in 2021, sourced directly from the official regulator.

77 Filings

2021 Period

2021 filings (77)

Filing	Released	Lang
Next Day Disclosure Return Share Issue/Capital Change	2021-12-21	English
(I) AMENDMENTS TO THE SCHEME RULES OF THE 2021 SHARE AWARD SCHEME; (II) APPOINTMENT OF TRUSTEE FOR ADMINISTERING THE 2021 SHARE AWARD SCHEME; AND (III) PLAN TO SATISFY PART OF THE AWARD SHAR Regulatory Filings	2021-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2021 Regulatory Filings	2021-12-03	English
Next Day Disclosure Return Share Issue/Capital Change	2021-11-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2021 Regulatory Filings	2021-11-04	English
VOLUNTARY ANNOUNCEMENT CDE APPROVAL RECEIVED FOR CLINICAL TRIAL OF CLASS I NEW DRUG OT-202 IN CHINA Regulatory Filings	2021-10-12	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2021 Regulatory Filings	2021-10-07	English
GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME AND GRANT OF AWARDS UNDER THE 2021 SHARE AWARD SCHEME Regulatory Filings	2021-09-30	English
Next Day Disclosure Return Share Issue/Capital Change	2021-09-24	English
Next Day Disclosure Return Share Issue/Capital Change	2021-09-23	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2021-09-20	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2021-09-20	English
2021 Interim Report Regulatory Filings	2021-09-20	English
VOLUNTARY ANNOUNCEMENT THE SIXTH PRODUCT OF THE COMPANY ENTERED PHASE III CLINICAL TRIAL STAGE - CDE APPROVAL RECEIVED FOR COMMENCEMENT OF A PHASE III CLINICAL TRIAL OF OT-502 (DEXYCU) IN CHINA Regulatory Filings	2021-09-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2021 Regulatory Filings	2021-09-06	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON AUGUST 31, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-31	English
DISCLOSEABLE TRANSACTION ACQUISITION OF RIGHTS RELATING TO EMADINE AND BETOPTIC S IN CHINA Capital/Financing Update	2021-08-24	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021 Interim / Quarterly Report	2021-08-20	English
VOLUNTARY ANNOUNCEMENT OT-502 APPROVED FOR REAL WORLD STUDY IN HAINAN BOAO Regulatory Filings	2021-08-17	English
COMPLETION OF ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE Capital/Financing Update	2021-08-13	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2021-08-10	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2021-08-10	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDAY, AUGUST 31, 2021 Proxy Solicitation & Information Statement	2021-08-10	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2021-08-10	English
(1) PROPOSED ADOPTION OF THE 2021 SHARE OPTION SCHEME; (2) PROPOSED GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME; (3) CONNECTED TRANSACTION INVOLVING PROPOSED GRANT OF AWARDS UNDER TH Proxy Solicitation & Information Statement	2021-08-10	English
NOTICE OF BOARD MEETING Regulatory Filings	2021-08-10	English
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO PROPOSED ADOPTION OF 2021 SHARE OPTION SCHEME, PROPOSED GRANT OF OPTIONS AND PROPOSED GRANT OF AWARDS UNDER 2021 SHARE AWARD SCHEME Regulatory Filings	2021-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2021 Regulatory Filings	2021-08-05	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2021 Regulatory Filings	2021-08-05	English
VOLUNTARY ANNOUNCEMENT MHRA APPROVAL RECEIVED FOR A PHASE III CLINICAL TRIAL OF OT-101 IN THE UNITED KINGDOM Regulatory Filings	2021-08-02	English
List of Directors and their Role and Function Board/Management Information	2021-07-20	English
RE-DESIGNATION OF EXECUTIVE DIRECTORS AS NON-EXECUTIVE DIRECTORS Board/Management Information	2021-07-20	English
VOLUNTARY ANNOUNCEMENT CDE APPROVAL RECEIVED FOR A PHASE III CLINICAL TRIAL OF OT-101 Regulatory Filings	2021-07-13	English
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF OT-502 APPROVED IN CHINA Regulatory Filings	2021-07-08	English
VOLUNTARY ANNOUNCEMENT OT-502 APPROVED FOR URGENT MEDICAL NEEDS IN HAINAN Regulatory Filings	2021-07-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2021 Capital/Financing Update	2021-07-05	English
(I) PROPOSED ADOPTION OF 2021 SHARE OPTION SCHEME AND PROPOSED GRANT OF OPTIONS; (II) ADOPTION OF 2021 SHARE AWARD SCHEME; AND (III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED GRANT OF AWAR Regulatory Filings	2021-07-02	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 29, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-06-29	English
CLARIFICATION ANNOUNCEMENT IN RELATION TO PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDERS Capital/Financing Update	2021-06-15	English
INSIDE INFORMATION PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDERS Major Shareholding Notification	2021-06-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2021 Capital/Financing Update	2021-06-04	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2021-05-27	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2021-05-27	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, JUNE 29, 2021 AGM Information	2021-05-27	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-05-27	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED GRANTING OF SPECIFIC MANDATE TO ISSUE UNLISTED WARRANTS AND Proxy Solicitation & Information Statement	2021-05-27	English
VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL AUTHORIZATION FOR INITIATING A PHASE III CLINICAL TRIAL OF OT-101 ACCEPTED IN UNITED KINGDOM Regulatory Filings	2021-05-20	English
Next Day Disclosure Return Transaction in Own Shares	2021-05-13	English
VOLUNTARY ANNOUNCEMENT IND APPLICATION RECEIVED FOR A PHASE III CLINICAL TRIAL OF OT-101 IN CHINA Regulatory Filings	2021-05-11	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020 Share Issue/Capital Change	2021-05-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2021 Share Issue/Capital Change	2021-05-06	English
2020 Environmental, Social and Governance Report Environmental & Social Information	2021-04-30	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2021-04-29	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2021-04-29	English
2020 Annual Report Regulatory Filings	2021-04-29	English
COMPLETION OF THE TRANSACTIONS UNDER SHARE PURCHASE AGREEMENT Capital/Financing Update	2021-04-23	English
VOLUNTARY ANNOUNCEMENT APPROVAL FOR COMMENCEMENT OF INITIAL PEDIATRIC STUDY PLAN FOR OT-101 IN THE UNITED STATES Regulatory Filings	2021-04-22	English
(I) DISCLOSEABLE TRANSACTIONS RELATING TO THE EXCLUSIVE LICENSE AGREEMENT AND THE SHARE PURCHASE AGREEMENT AND (II) THE WARRANT SUBSCRIPTION AGREEMENT WITH ALIMERA SCIENCES, INC. Capital/Financing Update	2021-04-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2021 Capital/Financing Update	2021-04-08	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE III CLINICAL TRIAL OF OT-101 IN THE UNITED STATES AND THE PLANNED REAL WORLD STUDY FOR OT-101 IN CHINA Regulatory Filings	2021-04-07	English
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR OT-401 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2021-04-07	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020 Annual Report	2021-03-19	English
List of Directors and their Role and Function Board/Management Information	2021-03-19	English
CHANGE OF NON-EXECUTIVE DIRECTOR Board/Management Information	2021-03-19	English
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT Regulatory Filings	2021-03-15	English
DATE OF BOARD MEETING Regulatory Filings	2021-03-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2021 Share Issue/Capital Change	2021-03-04	English
VOLUNTARY ANNOUNCEMENT SECOND PHASE III CLINICAL TRIAL OF OT-301 APPROVED IN CHINA Regulatory Filings	2021-03-03	English
VOLUNTARY ANNOUNCEMENT SELECTION OF THE SHARES OF THE COMPANY AS A CONSTITUENT OF CERTAIN INDEXES OF HANG SENG INDEXES COMPANY LIMITED Regulatory Filings	2021-03-01	English
VOLUNTARY ANNOUNCEMENT IND APPROVAL RECEIVED FOR A PHASE III CLINICAL TRIAL OF OT-101 IN THE UNITED STATES Regulatory Filings	2021-02-22	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN A PHASE III CLINICAL TRIAL OF OT-702 IN CHINA Regulatory Filings	2021-02-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2021 Major Shareholding Notification	2021-02-04	English
Next Day Disclosure Return Share Issue/Capital Change	2021-01-22	English
COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE Capital/Financing Update	2021-01-22	English
PLACING OF EXISTING SHARES TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE Capital/Financing Update	2021-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2020 Share Issue/Capital Change	2021-01-06	English
DISCLOSEABLE TRANSACTION SUBSCRIPTION OF SHARES IN EYEPOINT PHARMACEUTICALS, INC. Capital/Financing Update	2021-01-04	English